The company said an experimental stem cell therapy developed by its U.S. subsidiary BlueRock had shown signs of easing Parkinson’s disease symptoms in an early 12-patient trial.
Tag Archive for: BlueRock
The company’s subsidiary BlueRock has become the first company to report initial success treating Parkinson’s disease in humans using an experimental stem cell therapy, the drugmaker said on Wednesday.